PPWR: The EU Regulation Transforming Pharmaceutical Packaging

Intro

Every day, billions of medicines are manufactured, packaged and distributed around the world. Tablets and capsules travel through complex supply chains before finally reaching pharmacies and patients. Behind each of these medicines lies a sophisticated system of packaging technologies designed to protect pharmaceutical products from moisture, oxygen, light and contamination.

For decades, the primary objective of pharmaceutical packaging was clear: maximum safety and stability for medicines. But a new European regulation is adding another dimension.

The Role of the PPWR

The Packaging and Packaging Waste Regulation (PPWR) is one of the most significant regulatory reforms affecting the packaging industry in recent decades. As part of the European Green Deal and circular economy strategy, the regulation aims to reduce packaging waste while increasing recycling and material efficiency across Europe.

The PPWR introduces several key objectives:

  • reducing packaging waste
  • improving recyclability of packaging materials
  • increasing recycled content
  • strengthening extended producer responsibility.

The 2030 Target

One of the most important milestones of the PPWR is the year 2030. By that time, packaging placed on the EU market should be recyclable by design. For many industries this represents a technical challenge.

For pharmaceutical packaging, however, it represents a structural transformation. Because medicines require a level of protection that many other products do not. And the dominant packaging format used today — the blister pack — was never designed with recycling in mind.

Transition

To understand this challenge, it is necessary to first explore why pharmaceutical packaging is fundamentally different from most other packaging types.

👉 Next Episode:
Why pharmaceutical packaging is fundamentally different from conventional packaging.´

Tags